Fig. 3.
Association of microbial communities with COVID-19 conditions and co-morbidities. (a) Non-metric multidimensional scaling showed difference in the microbial community composition between symptomatic and asymptomatic infected patients. (b) Identification of differentially-abundant genera between symptomatic and asymptomatic infected patients. (c) Microbial community composition at genera-level between infected patients with or without comorbidities. (d) Identification of differentially-abundant genera in infected patients with or without comorbidities.